Research on an in vitro cell system for testing the neurotoxicity of kynurenine pathway metabolites

Pharmazie

Volumn 66, Issue 11, 2011, Pages 899-903

  Wszelaki, N ^a   Melzig, Matthias M F ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; GALACTOSE; GLUCOSE; KYNURENINE; OXIDOPAMINE; QUINOLINIC ACID; RETINOIC ACID; SALSOLINOL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL METABOLISM; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROTOXICITY;

BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; COLORING AGENTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROXYDOPAMINES; ISOQUINOLINES; KYNURENINE; NEUROBLASTOMA; NEUROTOXINS; QUINOLINIC ACID; TETRAZOLIUM SALTS; THIAZOLES; TRETINOIN;

EID: 84055217335     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.1560     Document Type: Article

References (30)

1. Behan WM, McDonald M, Darlinton LG, Stone TW (1999) Oxidative stress as a mechanism for quinolinic acid induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128: 1754-1760. (Pubitemid 30011889)
2. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, cytogenetics of humanneuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652.
3. Cheung YT, Lau WKW, Yu MS, Lai CSW, Yeung SC, So KF, Chang RCC (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30: 127-135.
4. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75: 991-1003. (Pubitemid 30660487)
5. Floyd RA (1999) Meuroinflammatory processes are important in neurodegenerative doseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radical Biol. Med 26: 1346-1355.
6. Galindo MF, Jordan J, Gonzales-Garcia C, Cena V (2003) Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation. J Neurochem 84: 1066-1073. (Pubitemid 36330659)
7. Garthwaite G, Garthwaite J (1987) Receptor linked ionic channels mediate N-methyl aspartate neurotoxicity inrat cerebellar slices. Neurosci. Lett. 83: 241-246. (Pubitemid 18001458)
8. Gomez-Lazaro M, Bonekamp NA, Galindo MF, Jordan J, Schrader M (2008) 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells Free Radic Biol Med 1960-1969.
9. Guillemin GJ, Kerr SJ, Brew BJ (2005) Involvement of quinolonic acid in human brain cultures. J Neurovirol 5-6: 375-380.
10. Jeong JH, Kim HJ, Lee TJ, Kim MK, Park ES, Choi BS (2004) Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. Toxicology 195: 53-60. (Pubitemid 38036982)
11. Lee MW, Lee HJ, Bach JH, Park SC, Park JS, Lee KH, Yeo JH, Lee WB, Lee SH, Kim SS (2005) Down-regulated reactive oxygen species by HSP90 in 3-HK-induced SK-N-SH cell death. J Therm Biol 30: 43-49. (Pubitemid 39550404)
12. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795. (Pubitemid 44622683)
13. Mak YT, Lam WP, LÜ L, Wong YW, Yew DT (2010) The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Miscrosc Res Tech 73: 195-201.
14. Marroquin LD, Hynes J, Dykens JA, Jamieson JD, Will Y (2007) Circumventing the crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97: 539-547. (Pubitemid 47073868)
15. Mattson MP, Barger SW, Furakawa K, Bruce AJ, Wyss-Coray T, Mark RJ, Mucke L (1997) Cellular signalling of TGFβ, TNF-α, βAPP in brain injury responses and Alzheimer's disease. Brain Res Rev 23: 47-61. (Pubitemid 27090749)
16. Maury CPJ (1995) Biology of disease; molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab Invest 72: 4-16.
17. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
18. Obregon E, Punzon MC, Gonzales-Nicolas J, Fernandez-Cruz E, Fresno M, MA Munoz-Fernandez (1997) Induction of adhesion/differentation of human neuroblastoma cells by tumor necrosis factor-α requires the expression of an inducible nitric oxide synthase. Eur J Eurosci 9: 1184-1193. (Pubitemid 27260747)
19. Okuda S, Nishiyama N, Saito H, Katsuki H (1996) Hydrogen peroxide-mediated neuronal cell death induced by an nedogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci USA 93: 12553-12558. (Pubitemid 26367182)
20. Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70: 299-307. (Pubitemid 28020856)
21. Pahlman S, Ruusala AI, Abrahamsson L, Mattson MEK, Esscher T (1984) Retinoic acid -induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Differ 14: 135-144. (Pubitemid 14089031)
22. Pizzi M, Boroni F, Bianchetti A, Moraitis C, Sarnico I, Benarese M, Gofii F, Valerio A, Spano PF (2002) Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 16: 2342-2350.
23. Rodriguez-Enriquez S, Juarez O, Rodriguez-Zavala JS, Moreno-Sanchez R (2001) Multisite control of the Crabtree effect in ascites hepatoma cells Eur. J. Biochem 268: 2512-2519. (Pubitemid 32417780)
24. Rozsa E, Robotka H., Vecsei L, Toldi J (2008) The Janus-face kynurenic acid. J Neural Transm 115: 1087-1091.
25. Shimizu E, Hashimoto K, Komatsu N, Iyo M (2002) Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoprotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43: 434-443. (Pubitemid 35257935)
26. Storch A, Kaftan A, Burkhardt K, Schwarz J (2000) 1-Methyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline salsolinol is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res 855: 67-75. (Pubitemid 30067695)
27. Ungerstedt U (1976) 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome. Pharmacol Ther B 2: 37-40.
28. Wainwright LJ, La sorella A, Iavarone A (2001) Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells Proc Natl Acad Sci USA 98: 9396-9400.
29. Wanpen S, Govitrapong P, Shavali S, Sangchot P, Ebadi M (2004) Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein. Brain Res 1005: 67-76. (Pubitemid 38388402)
30. von Coelln R, Kugler S, Bahr M, Weller M, Dichgans J, Schulz JB (2001) Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J Neurochem 77: 263-273. (Pubitemid 32245100)